We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

By LabMedica International staff writers
Posted on 16 Dec 2025

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients. More...

In 2022 alone, contaminated syrups were linked to the deaths of more than 300 children in Indonesia, The Gambia, Uzbekistan, and Cameroon. More recently, at least 24 additional deaths were reported in India. These incidents were traced to toxic industrial chemicals mistakenly or fraudulently used in place of pharmaceutical-grade ingredients. Now, researchers are developing simple, rapid, and inexpensive tests that can reliably detect these deadly contaminants, offering a practical way to prevent future tragedies.

Researchers at the University of Oxford (Oxford, UK), working with international collaborators, have demonstrated that commonly available alcohol detection tools can be repurposed to identify harmful contaminants in medicinal syrups and their raw ingredients. In research published in Nature Scientific Reports, the team tested two low-cost tools, each costing less than GBP 1. Alcohol test strips, typically used to detect traces of alcohol in saliva or breast milk, were able to identify contaminants in syrups and raw materials in under two minutes. Disposable breathalyzers, also designed for alcohol detection, flagged contamination in raw materials in as little as ten seconds.

Current detection methods rely on gas chromatography or thin-layer chromatography, which are slow, require hazardous solvents, and need trained technicians. In contrast, the new approach is water-based, rapid, and supported by a simple step-by-step protocol that can be followed by inspectors, regulators, and manufacturers. Together, these tools provide a fast, affordable, and easy-to-use screening method that could be deployed throughout pharmaceutical supply chains, especially in low-resource settings where advanced laboratory testing is unavailable.

By adapting tools that are widely available and inexpensive, the team believes on-the-spot testing could become a practical safeguard for vulnerable populations. The researchers hope these rapid tests can be adopted quickly to strengthen medicine safety checks and reduce the risk of future outbreaks linked to contaminated syrups.

“Urgent interventions are needed to be implemented to prevent these recurring tragedies of childhood deaths, and screening devices for detecting the toxins offer great promise in enabling this,” said project leader, Professor Paul Newton.

“Our findings show that solutions to this devastating global problem may already be within reach,” added study co-leader Professor Nicole Zitzmann. “By adapting tools that are widely available and inexpensive, we can enable on-the-spot testing to protect vulnerable children.”

Related Links
University of Oxford


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.